Literature DB >> 35705882

Eculizumab as a fast-acting rescue therapy in a refractory myasthenic crisis: a case report.

Camilla M M Strano1,2, Benedetta Sorrenti1,2, Luca Bosco1,2, Yuri M Falzone1, Raffaella Fazio1, Massimo Filippi3,4,5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35705882     DOI： 10.1007/s00415-022-11222-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   6.682


× No keyword cloud information.
  1 in total

Review 1.  Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management.

Authors:  Fiammetta Vanoli; Renato Mantegazza
Journal:  Neurotherapeutics       Date:  2022-02-14       Impact factor: 6.088
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.